Bioactive Compounds
-
A3658 NG25Summary: TAK1 inhibitor -
A3670 NucleozinSummary: Targets influenza A nucleoprotein (NP),cell-permeable isoxazolylpiperazine compound -
A3681 OlmesartanSummary: Angiotensin II receptor antagonist -
A3686 OrteronelSummary: For castration-resistant prostate cancer, clinical candidate -
A3699 PAP-1Summary: Kv1.3 inhibitor -
A3707 Pemetrexed disodium hemipenta hydrateSummary: Antifolate and antimetabolite agent -
A3711 PF-03084014Summary: γ-secretase inhibitor -
A3716 PF-37583091 CitationTarget: PAKSummary: PAK4 inhibitor -
A3717 PF-5431 CitationTarget: Sphingosine kinases (SphKs)Summary: SphK1 inhibitor,cell-permeate,potent and selective -
A3718 PF-543 CitrateSummary: SphK1 inhibitor,potent and cell-permeate

